The IARC Perspective on Alcohol Reduction or Cessation and Cancer Risk

Susan M Gapstur¹, Véronique Bouvard¹, Suzanne T Nethan¹+16

• ¹From the International Agency for Research on Cancer, Lyon, France (S.M.G., V.B., S.T.N., B.L.-S.); the School of Public Health and Health Professions, University at Buffalo, Buffalo (J.L.F.), and the Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, Columbia University, New York (M.B.T.) - both in New York; the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (C.C.A., K.A.M.); Cancer Council Victoria and Melbourne School of Population and Global Health, University of Melbourne, Melbourne (D.R.E.), and the University of Newcastle, Callaghan, NSW (P.B.) - both in Australia; the Centre for Addiction and Mental Health, Toronto (J.R.); the School of Public Health, University of Minnesota, Minneapolis (S.B.); Eskenazi Health and Indiana University School of Medicine, Indianapolis (D.C.); the School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, United Kingdom (D.I.C.); American Cancer Society, Atlanta (F.I.); Chemical and Veterinary Investigation Agency Karlsruhe, Karlsruhe, Germany (D.W.L.); University of Helsinki, Helsinki (M.S.); the Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo (N.S.); and the School of Public Health, Universidade de São Paulo, São Paulo (T.T.).